A:	SECTION A HUMAN NECESSITIES
A61:	MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P:	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P1/00:	Drugs for disorders of the alimentary tract or the digestive system
A61P1/02:	. Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
A61P1/04:	. for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P1/06:	. Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
A61P1/08:	. for nausea, cinetosis or vertigo; Antiemetics
A61P1/10:	. Laxatives
A61P1/12:	. Antidiarrhoeals
A61P1/14:	. Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
A61P1/16:	. for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A61P1/18:	. for pancreatic disorders, e.g. pancreatic enzymes
A61P3/00:	Drugs for disorders of the metabolism
A61P3/02:	. Nutrients, e.g. vitamins, minerals
A61P3/04:	. Anorexiants; Antiobesity agents
A61P3/06:	. Antihyperlipidemics
A61P3/08:	. for glucose homeostasis
A61P3/10:	. . for hyperglycaemia, e.g. antidiabetics
A61P3/12:	. for electrolyte homeostasis
A61P3/14:	. . for calcium homeostasis
A61P5/00:	Drugs for disorders of the endocrine system
A61P5/02:	. of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
A61P5/04:	. . for decreasing, blocking or antagonising the activity of the hypothalamic hormones
A61P5/06:	. of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
A61P5/08:	. . for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
A61P5/10:	. of the posterior pituitary hormones, e.g. oxytocin, ADH
A61P5/12:	. . for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
A61P5/14:	. of the thyroid hormones, e.g. T3, T4
A61P5/16:	. . for decreasing, blocking or antagonising the activity of the thyroid hormones
A61P5/18:	. of the parathyroid hormones
A61P5/20:	. . for decreasing, blocking or antagonising the activity of PTH
A61P5/22:	. . for decreasing, blocking or antagonising the activity of calcitonin
A61P5/24:	. of the sex hormones
A61P5/26:	. . Androgens
A61P5/28:	. . Antiandrogens
A61P5/30:	. . Oestrogens
A61P5/32:	. . Antioestrogens
A61P5/34:	. . Gestagens
A61P5/36:	. . Antigestagens
A61P5/38:	. of the suprarenal hormones
A61P5/40:	. . Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
A61P5/42:	. . for decreasing, blocking or antagonising the activity of mineralocorticosteroids
A61P5/44:	. . Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
A61P5/46:	. . for decreasing, blocking or antagonising the activity of glucocorticosteroids
A61P5/48:	. of the pancreatic hormones
A61P5/50:	. . for increasing or potentiating the activity of insulin
A61P7/00:	Drugs for disorders of the blood or the extracellular fluid
A61P7/02:	. Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A61P7/04:	. Antihaemorrhagics; Procoagulants; Haemostatatic agents; Antifibrinolytic agents
A61P7/06:	. Antianaemics
A61P7/08:	. Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
A61P7/10:	. Antioedematous agents; Diuretics
A61P7/12:	. Antidiuretics, e.g. drugs for diabetes insipidus
A61P9/00:	Drugs for disorders of the cardiovascular system
A61P9/02:	. Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
A61P9/04:	. Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
A61P9/06:	. Antiarrhythmics
A61P9/08:	. Vasodilators for multiple indications
A61P9/10:	. for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61P9/12:	. Antihypertensives
A61P9/14:	. Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
A61P11/00:	Drugs for disorders of the respiratory system
A61P11/02:	. Nasal agents, e.g. decongestants
A61P11/04:	. for throat disorders
A61P11/06:	. Antiasthmatics
A61P11/08:	. Bronchodilators
A61P11/10:	. Expectorants
A61P11/12:	. Mucolytics
A61P11/14:	. Antitussive agents
A61P11/16:	. Central respiratory analeptics
A61P13/00:	Drugs for disorders of the urinary system
A61P13/02:	. of urine or of the urinary tract, e.g. urine acidifiers
A61P13/04:	. for urolithiasis
A61P13/06:	. Anti-spasmodics
A61P13/08:	. of the prostate
A61P13/10:	. of the bladder
A61P13/12:	. of the kidneys
A61P15/00:	Drugs for genital or sexual disorders; Contraceptives
A61P15/02:	. for disorders of the vagina
A61P15/04:	. for inducing labour or abortion; Uterotonics
A61P15/06:	. Antiabortive agents; Labour repressants
A61P15/08:	. for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
A61P15/10:	. for impotence
A61P15/12:	. for climacteric disorders
A61P15/14:	. for lactation disorders, e.g. galactorrhoea
A61P15/16:	. Masculine contraceptives
A61P15/18:	. Feminine contraceptives
A61P17/00:	Drugs for dermatological disorders
A61P17/02:	. for treating wounds, ulcers, burns, scars, keloids, or the like
A61P17/04:	. Antipruritics
A61P17/06:	. Antipsoriatics
A61P17/08:	. Antiseborrheics
A61P17/10:	. Anti-acne agents
A61P17/12:	. Keratolytics, e.g. wart or anti-corn preparations
A61P17/14:	. for baldness or alopecia
A61P17/16:	. Emollients or protectives, e.g. against radiation
A61P17/18:	. Antioxidants, e.g. antiradicals
A61P19/00:	Drugs for skeletal disorders
A61P19/02:	. for joint disorders, e.g. arthritis, arthrosis
A61P19/04:	. for non-specific disorders of the connective tissue
A61P19/06:	. Antigout agents, e.g. antihyperuricemic or uricosuric agents
A61P19/08:	. for bone diseases, e.g. rachitism, Paget's disease
A61P19/10:	. . for osteoporosis
A61P21/00:	Drugs for disorders of the muscular or neuromuscular system
A61P21/02:	. Muscle relaxants, e.g. for tetanus or cramps
A61P21/04:	. for myasthenia gravis
A61P21/06:	. Anabolic agents
A61P23/00:	Anaesthetics
A61P23/02:	. Local anaesthetics
A61P25/00:	Drugs for disorders of the nervous system
A61P25/02:	. for peripheral neuropathies
A61P25/04:	. Centrally acting analgesics, e.g. opioids
A61P25/06:	. Antimigraine agents
A61P25/08:	. Antiepileptics; Anticonvulsants
A61P25/10:	. . for petit-mal
A61P25/12:	. . for grand-mal
A61P25/14:	. for treating abnormal movements, e.g. chorea, dyskinesia
A61P25/16:	. . Anti-Parkinson drugs
A61P25/18:	. Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
A61P25/20:	. Hypnotics; Sedatives
A61P25/22:	. Anxiolytics
A61P25/24:	. Antidepressants
A61P25/26:	. Psychostimulants, e.g. nicotine, cocaine
A61P25/28:	. for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P25/30:	. for treating abuse or dependence
A61P25/32:	. . Alcohol-abuse
A61P25/34:	. . Tobacco-abuse
A61P25/36:	. . Opioid-abuse
A61P27/00:	Drugs for disorders of the senses
A61P27/02:	. Ophthalmic agents
A61P27/04:	. . Artificial tears; Irrigation solutions
A61P27/06:	. . Antiglaucoma agents or miotics
A61P27/08:	. . Mydriatics or cycloplegics
A61P27/10:	. . for accommodation disorders, e.g. myopia
A61P27/12:	. . for cataracts
A61P27/14:	. . Decongestants or antiallergics
A61P27/16:	. Otologicals
A61P29/00:	Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61P29/02:	. without antiinflammatory effect
A61P31/00:	Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/02:	. Local antiseptics
A61P31/04:	. Antibacterial agents
A61P31/06:	. . for tuberculosis
A61P31/08:	. . for leprosy
A61P31/10:	. Antimycotics
A61P31/12:	. Antivirals
A61P31/14:	. . for RNA viruses
A61P31/16:	. . . for influenza or rhinoviruses
A61P31/18:	. . . for HIV
A61P31/20:	. . for DNA viruses
A61P31/22:	. . . for herpes viruses
A61P33/00:	Antiparasitic agents
A61P33/02:	. Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
A61P33/04:	. . Amoebicides
A61P33/06:	. . Antimalarials
A61P33/08:	. . for Pneumocystis carinii
A61P33/10:	. Anthelmintics
A61P33/12:	. . Schistosomicides
A61P33/14:	. Ectoparasiticides, e.g. scabicides
A61P35/00:	Antineoplastic agents
A61P35/02:	. specific for leukemia
A61P35/04:	. specific for metastasis
A61P37/00:	Drugs for immunological or allergic disorders
A61P37/02:	. Immunomodulators
A61P37/04:	. . Immunostimulants
A61P37/06:	. . Immunosuppressants, e.g. drugs for graft rejection
A61P37/08:	. Antiallergic agents
A61P39/00:	General protective or antinoxious agents
A61P39/02:	. Antidotes
A61P39/04:	. Chelating agents
A61P39/06:	. Free radical scavengers or antioxidants
A61P41/00:	Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
A61P43/00:	Drugs for specific purposes, not provided for in groups